Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines - News-Medical.Net

Broadly neutralizing antibodies are the blueprint for variant-proof, pansarbecovirus vaccines - News-Medical.Net
A recent Nature Reviews Immunology study has summarized the efficacy of neutralizing antibodies that target four main regions of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), namely, the receptor-binding domain (RBD) i…
A recent Nature Reviews Immunology study has summarized the efficacy ofneutralizing antibodies that target four main regions of the spike (S) protein of severe acute respiratory syndrome coronavirus … [+5645 chars] Read More



Related Stories

See All